Access Bio Inc Capital Reinvestment Ratio
Access Bio Inc capital reinvestment ratio. Access Bio Inc (950130) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩5.35 Million) in capital expenditures (₩635.11K). See cash generation quality of Access Bio Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Access Bio Inc (2012–2024)
Capital reinvestment ratio of Access Bio Inc from 2012 to 2024. This chart tracks Access Bio Inc's Capital Reinvestment Ratio across 8 annual periods. See how financially flexible is Access Bio Inc to measure the company's free cash flow as a share of total liabilities.
Access Bio Inc Capital Reinvestment Ratio by Year (2012–2024)
Access Bio Inc capital reinvestment ratio by year from 2012 to 2024. For the full cash flow conversion analysis, see how efficiently does Access Bio Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | ₩13.54 Million | ₩1.40 Million | ▲ +101.5% |
| 2022 | 0.05x | ₩291.33 Million | ₩14.90 Million | ▼ -75.5% |
| 2021 | 0.21x | ₩137.90 Million | ₩28.76 Million | ▼ -26.3% |
| 2020 | 0.28x | ₩36.72 Billion | ₩10.38 Billion | ▼ -94.0% |
| 2016 | 4.74x | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.85 Billion | ₩1.31 Billion | — |